This summer PepsiCo’s (NYSE: PEP) Mountain Dew® (DEW) is celebrating the permanent return of Mountain Dew Throwback® – retro DEW made with real sugar – with an online “Throwback Shack” designed to immerse consumers in the vintage brand. The Shack was created to provide an interactive experience representative of the home of Willy, the 1960s animated Mountain Dew pitchman. As part of this digital experience, Willy will share his favorite DEW® collectibles from over the years with all the brand’s fans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50933-mountain-dew-throwback-shack
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
Monster (NYSE: MWW), a global leader in connecting people to jobs, and Brandwatch, the leading social intelligence company, today announced the results of a year-long social media study of more than 1.1 million tweets in the United States analyzing exactly who, what, when, where and why people take to Twitter to discuss how they feel about their jobs.
“It’s certainly not just the weather nor differences in temperament that drove the disparity between people in the east hating their jobs and people in the west loving them,” said Joanie Courtney, Senior Vice President, Global Market Insights at Monster. “Job satisfaction is an often fluid, temporary sensation, and social channels deliver people the opportunity to express those sentiments with greater ease than ever before. The results indicate an opportunity for companies to focus on embracing existing talent to move the ‘love-hate needle,’ as well as those Tweeting to translate their skills for new opportunities to find something better.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7470451-monster-brandwatch-social-media-study/
Several projects across platforms and crops designed to improve farmers’ on-farm productivity and profitability advanced phases today as part of Monsanto Company’s (NYSE: MON) annual pipeline update.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/monsanto/48030/
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62776-merck-for-mothers-working-to-reduce-maternal-mortality-rate
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
IMAX Corporation (NYSE:IMAX; TSX:IMX) and Paramount Pictures today announced that Mission: Impossible – Ghost Protocol The IMAX Experience will begin previews in IMAX on Friday, Dec. 16, five days in advance of the film’s North American wide release on Dec. 21. Domestically, the film will open in approximately 300 IMAX® theatres and play through the film’s run at the box office.
Internationally, the film will open on approximately 200 IMAX screens beginning on Dec. 14, with several markets receiving an early window release in IMAX ahead of their wide release, including six days in the Netherlands, five days in the UK, three days in France and Poland, two days in Korea, Spain and Taiwan, and one day in various other countries worldwide.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53535-mission-impossible-ghost-protocol-the-imax-experience
History was made today in Mississippi, as two Magnolia State resorts, Beau Rivage Resort & Casino in Biloxi and Gold Strike Casino Resort in Tunica, held simultaneous events to usher in the era of legal sports wagering.
The resorts, part of the MGM Resorts International portfolio (NYSE: MGM), both accepted their first sports wagers at 12:00 p.m. CT and now share in the distinction of taking the first sports wagers in Mississippi under newly created state regulations permitting licensed casino operators to establish legal sports books.
“MGM Resorts is proud to once again assume the leadership position in the hospitality industry,” said Jim Murren, chairman and chief executive officer of MGM Resorts International. “Sports wagering is a rapidly growing, exciting new entertainment opportunity for our company. We were proud to take the first sports wager in Atlantic City in June and today the first legal sports wager in two locations in Mississippi.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8372951-mgm-beau-rivage-sports-book-and-bar-mississippi-first-bet/
MGM Resorts International (NYSE: MGM) unveiled details today about the experience it is creating in Las Vegas surrounding the world-class 20,000-seat arena under development in partnership with renowned sports, entertainment and facilities organization AEG. Plans include new Stripside experiences at New York-New York and Monte Carlo resorts and a public park leading to the new state-of-the-art arena. The Company also announced details about the team who will bring this robust new experience to fruition.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61204-mgm-resorts-unveils-plans-for-las-vegas-entertainment-district-arena
MGM MIRAGE (NYSE:MGM) shareholders today approved at their annual meeting a proposal to rebrand the iconic hospitality leader “MGM Resorts International.” In addition, the Company announced today that it will relaunch its Players Club loyalty program as M life.
Today, MetroPCS Communications Inc. (NYSE: PCS) became the first mobile operator to launch commercial 4G LTE services in the United States, offering talk, text and 4G Web access starting as low as $55 per month including taxes and regulatory fees. MetroPCS is also offering the world’s first commercially available 4G LTE enabled handset, the Samsung Craft™. Service will initially be available in Las Vegas, Nev., with service expanding into the remaining MetroPCS cities throughout the year.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/metropcs/46037/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
